USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.04 | $-0.00 | $0.02 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $9.19M | $9.06M | $9.25M |
Cumberland Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $0.06 | $0.06 | $0.06 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $0.09 | $0.09 | $0.09 |
| Dec 2022 | 1 | $0.14 | $0.14 | $0.14 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 1 | $0.06 | $0.08 | $0.08 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 1 / 0 | $0.09 | $0.08 | $0.08 |
| Dec 2022 | 1 / 0 | $0.14 | $0.10 | $0.10 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $12.18M | $12.18M | $12.18M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $40.97M | $40.97M | $40.97M |
| Dec 2022 | 1 | $44.85M | $44.85M | $44.85M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.04 | - | - |
| Aug 10, 2021 | Jun 2021 | $-0.07 | $-0.00 | 98.43% |
| May 11, 2021 | Mar 2021 | $-0.07 | $0.07 | 200.00% |
| Mar 9, 2021 | Dec 2020 | $-0.01 | $0.01 | 200.00% |
| Nov 10, 2020 | Sep 2020 | $-0.07 | $0.02 | 128.57% |
| Aug 11, 2020 | Jun 2020 | $0.03 | $0.08 | 166.67% |
| May 20, 2020 | Mar 2020 | $0.02 | $0.01 | -50.00% |
| Mar 18, 2020 | Dec 2019 | $0.01 | $0.09 | 800.00% |
| Nov 12, 2019 | Sep 2019 | $0.11 | $0.01 | -90.91% |
| Aug 14, 2019 | Jun 2019 | $0.07 | $0.10 | 42.86% |
| May 14, 2019 | Mar 2019 | $-0.11 | $0.11 | 200.00% |
| Feb 26, 2019 | Dec 2018 | $-0.16 | $0.10 | 162.50% |
| Nov 13, 2018 | Sep 2018 | $-0.19 | $-0.05 | 73.68% |
| Aug 14, 2018 | Jun 2018 | $-0.08 | $0.01 | 112.50% |
| May 8, 2018 | Mar 2018 | $-0.02 | $-0.09 | -350.00% |
| Mar 9, 2018 | Dec 2017 | $-0.02 | $-0.05 | -154.50% |
| Nov 7, 2017 | Sep 2017 | - | $-0.05 | - |
| Aug 8, 2017 | Jun 2017 | - | $-0.32 | - |
| May 15, 2017 | Mar 2017 | - | $-0.08 | - |
| Mar 7, 2017 | Dec 2016 | - | $-0.05 | - |
| Oct 25, 2016 | Sep 2016 | - | $0.01 | - |
| Aug 2, 2016 | Jun 2016 | - | $-0.00 | - |
| May 3, 2016 | Mar 2016 | - | $-0.02 | - |
| Mar 4, 2016 | Dec 2015 | - | $0.01 | - |
| Nov 4, 2015 | Sep 2015 | - | $0.01 | - |
| Aug 5, 2015 | Jun 2015 | - | $0.02 | - |
| May 8, 2015 | Mar 2015 | - | $0.00 | - |
| Mar 4, 2015 | Dec 2014 | - | $0.04 | - |
| Nov 5, 2014 | Sep 2014 | - | $0.04 | - |
| Aug 6, 2014 | Jun 2014 | - | $0.04 | - |
| May 14, 2014 | Mar 2014 | - | $0.02 | - |
| Mar 4, 2014 | Dec 2013 | $0.05 | $-0.08 | -260.00% |
| Nov 5, 2013 | Sep 2013 | - | $-0.04 | - |
| Aug 6, 2013 | Jun 2013 | $0.02 | $-0.03 | -250.00% |
| May 2, 2013 | Mar 2013 | $0.05 | $0.05 | - |
| Feb 28, 2013 | Dec 2012 | $0.14 | $0.12 | -14.29% |
| Nov 1, 2012 | Sep 2012 | $0.09 | $0.10 | 11.11% |
| Aug 2, 2012 | Jun 2012 | $0.07 | $0.09 | 28.57% |
| May 3, 2012 | Mar 2012 | $0.05 | $0.02 | -60.00% |
| Feb 29, 2012 | Dec 2011 | $0.05 | $0.04 | -20.00% |
| Nov 3, 2011 | Sep 2011 | $0.06 | $0.09 | 50.00% |
| Aug 4, 2011 | Jun 2011 | $0.04 | $0.11 | 175.00% |
| May 4, 2011 | Mar 2011 | $0.03 | $0.03 | - |
| Mar 8, 2011 | Dec 2010 | $0.03 | $0.04 | 33.33% |
| Nov 11, 2010 | Sep 2010 | $0.01 | $0.05 | 400.00% |
| Aug 16, 2010 | Jun 2010 | $0.03 | $0.01 | -66.67% |
| May 13, 2010 | Mar 2010 | $0.02 | $0.02 | - |
| Mar 10, 2010 | Dec 2009 | $0.01 | $0.01 | - |
| Nov 10, 2009 | Sep 2009 | $0.01 | $0.10 | 900.00% |
| Aug 27, 2009 | Jun 2009 | - | $0.02 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 9, 2021 | Dec 2020 | $-0.03 | $0.12 | - |
| Mar 18, 2020 | Dec 2019 | $0.24 | $0.31 | 29.17% |
| Feb 26, 2019 | Dec 2018 | $-0.29 | $-0.03 | - |
| Mar 9, 2018 | Dec 2017 | - | $-0.50 | - |
| Mar 7, 2017 | Dec 2016 | - | $-0.06 | - |
| Mar 4, 2016 | Dec 2015 | - | $0.04 | - |
| Mar 4, 2015 | Dec 2014 | - | $0.14 | - |
| Mar 4, 2014 | Dec 2013 | - | $-0.10 | - |
| Feb 28, 2013 | Dec 2012 | - | $0.33 | - |
| Feb 29, 2012 | Dec 2011 | - | $0.27 | - |
| Mar 8, 2011 | Dec 2010 | - | $0.12 | - |
| Mar 10, 2010 | Dec 2009 | - | $0.13 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $9.19M | - | - |
| Aug 10, 2021 | Jun 2021 | $9.05M | $9.06M | 1.00% |
| May 11, 2021 | Mar 2021 | $8.50M | $10.54M | 1.24% |
| Mar 9, 2021 | Dec 2020 | $9.78M | $10.26M | 1.05% |
| Nov 10, 2020 | Sep 2020 | $8.61M | $9.25M | 1.07% |
| Aug 11, 2020 | Jun 2020 | $9.27M | $9.60M | 1.04% |
| May 20, 2020 | Mar 2020 | $9.46M | $8.33M | 0.88% |
| Mar 18, 2020 | Dec 2019 | $11.34M | $13.68M | 1.21% |
| Nov 12, 2019 | Sep 2019 | $12.65M | $10.37M | 0.82% |
| Aug 14, 2019 | Jun 2019 | $12.59M | $11.58M | 0.92% |
| May 14, 2019 | Mar 2019 | $10.70M | $11.90M | 1.11% |
| Feb 26, 2019 | Dec 2018 | $10.98M | $13.50M | 1.23% |
| Nov 13, 2018 | Sep 2018 | $9.16M | $8.49M | 0.93% |
| Aug 14, 2018 | Jun 2018 | $9.94M | $10.16M | 1.02% |
| May 8, 2018 | Mar 2018 | $9.71M | $8.59M | 0.88% |
| Mar 9, 2018 | Dec 2017 | - | $11.65M | - |
| Nov 7, 2017 | Sep 2017 | - | $11.20M | - |
| Aug 8, 2017 | Jun 2017 | - | $8.67M | - |
| May 15, 2017 | Mar 2017 | - | $9.64M | - |
| Mar 7, 2017 | Dec 2016 | - | $9.08M | - |
| Oct 25, 2016 | Sep 2016 | - | $8.79M | - |
| Aug 2, 2016 | Jun 2016 | - | $7.41M | - |
| May 3, 2016 | Mar 2016 | - | $7.74M | - |
| Mar 4, 2016 | Dec 2015 | - | $8.04M | - |
| Nov 4, 2015 | Sep 2015 | - | $7.89M | - |
| Aug 5, 2015 | Jun 2015 | - | $8.91M | - |
| May 8, 2015 | Mar 2015 | - | $8.69M | - |
| Mar 4, 2015 | Dec 2014 | - | $9.33M | - |
| Nov 5, 2014 | Sep 2014 | - | $9.73M | - |
| Aug 6, 2014 | Jun 2014 | - | $9.75M | - |
| May 14, 2014 | Mar 2014 | - | $8.09M | - |
| Mar 4, 2014 | Dec 2013 | - | $8.16M | - |
| Nov 5, 2013 | Sep 2013 | - | $6.53M | - |
| Aug 6, 2013 | Jun 2013 | - | $7.08M | - |
| May 2, 2013 | Mar 2013 | - | $10.26M | - |
| Feb 28, 2013 | Dec 2012 | - | $13.70M | - |
| Nov 1, 2012 | Sep 2012 | - | $12.53M | - |
| Aug 2, 2012 | Jun 2012 | - | $12.37M | - |
| May 3, 2012 | Mar 2012 | - | $10.26M | - |
| Feb 29, 2012 | Dec 2011 | - | $13.03M | - |
| Nov 3, 2011 | Sep 2011 | - | $13.05M | - |
| Aug 4, 2011 | Jun 2011 | - | $14.39M | - |
| May 4, 2011 | Mar 2011 | - | $10.67M | - |
| Mar 8, 2011 | Dec 2010 | - | $12.81M | - |
| Nov 11, 2010 | Sep 2010 | - | $12.19M | - |
| Aug 16, 2010 | Jun 2010 | - | $10.74M | - |
| May 13, 2010 | Mar 2010 | - | $10.13M | - |
| Mar 10, 2010 | Dec 2009 | - | $10.71M | - |
| Nov 10, 2009 | Sep 2009 | - | $13.60M | - |
| Aug 27, 2009 | Jun 2009 | - | $9.82M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 9, 2021 | Dec 2020 | $36.96M | $37.44M | 1.30% |
| Mar 18, 2020 | Dec 2019 | $45.20M | $47.53M | 5.16% |
| Feb 26, 2019 | Dec 2018 | $38.23M | $40.74M | 6.57% |
| Mar 9, 2018 | Dec 2017 | - | $41.15M | - |
| Mar 7, 2017 | Dec 2016 | - | $33.03M | - |
| Mar 4, 2016 | Dec 2015 | - | $33.52M | - |
| Mar 4, 2015 | Dec 2014 | - | $36.90M | - |
| Mar 4, 2014 | Dec 2013 | - | $32.03M | - |
| Feb 28, 2013 | Dec 2012 | - | $48.85M | - |
| Feb 29, 2012 | Dec 2011 | - | $51.14M | - |
| Mar 8, 2011 | Dec 2010 | - | $45.88M | - |
| Mar 10, 2010 | Dec 2009 | - | $43.54M | - |
CPIX's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 1 analysts, the average EPS estimation for Cumberland Pharmaceuticals's next quarterly earnings is $-0.04, with a low EPS estimation of $-0.04, and a high estimation of $-0.04.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $-0.04, the last 2 month trend is $0.01, and the 3 month trend is $0.01.
Based on 1 analysts, the average revenue estimation is $9.19M, with a low revenue estimation of $9.19M, and a high estimation of $9.19M.
Cumberland Pharmaceuticals's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.
CPIX's earnings per share (EPS) was $-0.00, beating the consensus analysts forecast of $-0.07 by 98.43%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by -101.57%, and lower than the same period a year before (Jun 2020) by -101.38%.
Revenues were $9.06M, better than the forecast of $9.05M by 0.01%, down by -14.06% from the previous quarter , and down by -5.65% from the same period last year.
The company reported a net income of $1.23M.Free cash flow for the quarter was $2.65M , compared to $1.67M last quarter and $2.61M a year before.
CPIX ended the quarter with $15.58M in total debt, a decrease of -7.43% compared to the previous quarter, and a decrease of -20.30% compared to the same quarter a year before.
Cumberland Pharmaceuticals's previous annual earnings date was Mar 9, 2021 for its fiscal year ended Dec 31, 2020.
CPIX's earnings per share (EPS) was $0.12, beating the consensus analysts forecast of $-0.03 by -500.00% , and lower than the previous year's EPS (Dec 2019) by -61.29%.
Revenues were $37.44M, better than the forecast of $36.96M by 1.30%, and down by -21.23% from previous year's revenue.
The company reported a net income of $-3.34M.
Cumberland Pharmaceuticals reported a free cash flow of $3.30M for its fiscal year, compared to $2.04M a year ago.
The company ended the fiscal year with $18.20M in total debt, a decrease of -6.26% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
